NCT01782261View on ClinicalTrials.gov

Incretin Effect on the Immunological Phenotype

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Type 1 Diabetes
Interventions
DRUG

Liraglutide

once daily subcutaneous injection

DRUG

Saxagliptin

once daily tablet

Trial Locations (1)

8036

Medical University Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT01782261 - Incretin Effect on the Immunological Phenotype | Biotech Hunter | Biotech Hunter